Clinical profile and predictors of in-hospital mortality among older patients hospitalised for COVID-19

VM Becerra-Muñoz, IJ Núñez-Gil, CM Eid… - Age and …, 2021 - academic.oup.com
Background the coronavirus disease 2019 (COVID-19) is characterized by poor outcomes
and mortality, particularly in older patients. Methods post hoc analysis of the international …

Non-invasive ventilation for SARS-CoV-2 acute respiratory failure: a subanalysis from the HOPE COVID-19 registry

M Bertaina, IJ Nuñez-Gil, L Franchin… - Emergency Medicine …, 2021 - emj.bmj.com
Background The COVID-19 pandemic has seriously challenged worldwide healthcare
systems and limited intensive care facilities, leading to physicians considering the use of …

Does there exist an obesity paradox in COVID-19? Insights of the international HOPE-COVID-19-registry

M Abumayyaleh, IJN Gil, I El-Battrawy, V Estrada… - Obesity research & …, 2021 - Elsevier
Background Obesity has been described as a protective factor in cardiovascular and other
diseases being expressed as 'obesity paradox'. However, the impact of obesity on clinical …

COVID‐19 and the impact of arterial hypertension—An analysis of the international HOPE COVID‐19 Registry (Italy‐Spain‐Germany)

I El‐Battrawy, IJ Nuñez‐Gil… - European Journal of …, 2021 - Wiley Online Library
Background A systematic analysis of concomitant arterial hypertension in COVID‐19
patients and the impact of angiotensin‐converting‐enzyme inhibitors (ACEI) or angiotensin …

Anticoagulation therapy in patients with coronavirus disease 2019: Results from a multicenter international prospective registry (health outcome predictive evaluation …

F Santoro, IJ Núñez-Gil, MC Viana-Llamas… - Critical Care …, 2021 - journals.lww.com
OBJECTIVES: No standard therapy, including anticoagulation regimens, is currently
recommended for coronavirus disease 2019. Aim of this study was to evaluate the efficacy of …

Aspirin Therapy on Prophylactic Anticoagulation for Patients Hospitalized With COVID‐19: A Propensity Score‐Matched Cohort Analysis of the HOPE‐COVID‐19 …

F Santoro, IJ Núñez‐Gil, E Vitale… - Journal of the …, 2022 - Am Heart Assoc
Background COVID‐19 is an infectious illness, featured by an increased risk of
thromboembolism. However, no standard antithrombotic therapy is currently recommended …

[HTML][HTML] Impact of smoking on COVID-19 outcomes: a HOPE Registry subanalysis

C Espejo-Paeres, IJ Núñez-Gil, V Estrada… - … , Prevention & Health, 2021 - ncbi.nlm.nih.gov
Background Smoking has been associated with poorer outcomes in relation to COVID-19.
Smokers have higher risk of mortality and have a more severe clinical course. There is …

One-year readmissions for circulatory diseases and in-hospital mortality after an index episode of heart failure in elderly patients. A nationwide data from public …

A Esteban-Fernández, M Anguita-Sánchez… - Clinical Research in …, 2023 - Springer
Introduction Heart failure (HF) is one of the leading causes of hospitalization and death in
elderly patients. However, there is limited evidence on readmission and mortality 1-year …

[HTML][HTML] Clinical profile and prognosis of a real-world cohort of patients with moderate or severe cancer therapy-induced cardiac dysfunction

A Esteban-Fernández… - Frontiers in …, 2021 - frontiersin.org
Introduction and Objectives: Cancer therapy-related cardiac dysfunction (CTRCD) is a
common cause of cancer treatment withdrawal, related to the poor outcomes. The cardiac …

Renin-angiotensin system inhibitors effect before and during hospitalization in COVID-19 outcomes: Final analysis of the international HOPE COVID-19 (Health …

IJ Núñez-Gil, I Olier, G Feltes, MC Viana-Llamas… - American Heart …, 2021 - Elsevier
ABSTRACT Background The use of Renin-Angiotensin system inhibitors (RASi) in patients
with coronavirus disease 2019 (COVID-19) has been questioned because both share a …